Marks Group Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ResMed
RMD
|
+$8.88M |
| 2 |
Intuit
INTU
|
+$8.43M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.94M |
| 4 |
Schwab US Large- Cap ETF
SCHX
|
+$2.89M |
| 5 |
Icon
ICLR
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$10.5M |
| 2 |
Toro Company
TTC
|
+$7.18M |
| 3 |
Avery Dennison
AVY
|
+$6.86M |
| 4 |
UnitedHealth
UNH
|
+$6.18M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$3.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.67% |
| 2 | Technology | 18.69% |
| 3 | Financials | 18.06% |
| 4 | Healthcare | 11.9% |
| 5 | Consumer Discretionary | 8.21% |
Similar funds
Marks Group Wealth Management's Q1 2025 Portfolio in Review
As of Q1 2025, Marks Group Wealth Management held 312 positions worth $1.04B, up 2.4% from $1.02B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Marks Group Wealth Management deployed $36.4M of net new capital in Q1 2025, opening 26 new positions and adding to 125 existing holdings. Its largest new stake was ResMed: 38,031 shares worth $8.51M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Boston Scientific, an estimated $10.5M trimmed.
- Marks Group Wealth Management's largest Q1 2025 buy was ResMed: 38,031 shares worth $8.51M.
- Marks Group Wealth Management added most to Vanguard FTSE Developed Markets ETF in Q1 2025, an estimated $3.94M increase.
- Marks Group Wealth Management's biggest Q1 2025 reduction was Boston Scientific, cutting an estimated $10.5M.
- Marks Group Wealth Management fully exited Toro Company in Q1 2025, selling an estimated $7.18M.
- Marks Group Wealth Management's ten largest holdings make up 18% of its $1.04B portfolio in Q1 2025.
- Marks Group Wealth Management opened 26 new positions and closed 14 in Q1 2025.
- Marks Group Wealth Management's portfolio value rose 2.4% quarter-over-quarter to $1.04B.
Based on Marks Group Wealth Management's 13F filing for Q1 2025, filed 1 May 2025.